The FDA does regulate supplements to some extent, particularly regarding labeling and safety, but they do not evaluate their ...

Maintaining high energy levels, vitality, and stamina is essential for achieving personal and professional goals in today’s ...

Psyence Biomedical (PBM) announced that it has progressed beyond the previously-announced non-binding Letter of Intent, LOI, and executed ...

Merakris Therapeutics is pleased to announce that enrollment is now open for Part 2 of its Phase 2 multicenter, clinical trial (NCT04647240) of its investigational wound care drug, Dermacyte ® ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...